What is the Neuren Pharmaceuticals (ASX: NEU) share price?
The NEU share price is $12.42, down 2.51% for the day, based on the latest available ASX market data.
What is Neuren Pharmaceuticals's market capitalisation?
Neuren Pharmaceuticals has a market capitalisation of $1.57B, making it the 264th-largest security listed on the ASX.
Does Neuren Pharmaceuticals pay a dividend?
NEU does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
What is NEU's P/E ratio?
Neuren Pharmaceuticals trades on a trailing price-to-earnings (P/E) ratio of 38.25, based on its current share price and most recent reported earnings.
Is Neuren Pharmaceuticals profitable?
Yes. In its most recent reported period (ending 31 Dec 2025), NEU reported revenue of $36.4M and a net profit of $15.4M.
How many NEU shares are on issue?
Neuren Pharmaceuticals has approximately 126,773,972 shares on issue, based on its market capitalisation of $1.57B and current share price.
What sector is Neuren Pharmaceuticals in?
Neuren Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Neuren Pharmaceuticals list on the ASX?
Neuren Pharmaceuticals listed on the Australian Securities Exchange on 1 Feb 2005.
